- Hong Kong
- /
- Healthcare Services
- /
- SEHK:6078
There's Been No Shortage Of Growth Recently For Hygeia Healthcare Holdings' (HKG:6078) Returns On Capital
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an eye out for. Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. Put simply, these types of businesses are compounding machines, meaning they are continually reinvesting their earnings at ever-higher rates of return. So when we looked at Hygeia Healthcare Holdings (HKG:6078) and its trend of ROCE, we really liked what we saw.
What Is Return On Capital Employed (ROCE)?
If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. To calculate this metric for Hygeia Healthcare Holdings, this is the formula:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
0.10 = CN¥786m ÷ (CN¥9.0b - CN¥1.5b) (Based on the trailing twelve months to June 2023).
So, Hygeia Healthcare Holdings has an ROCE of 10%. In absolute terms, that's a pretty normal return, and it's somewhat close to the Healthcare industry average of 11%.
See our latest analysis for Hygeia Healthcare Holdings
In the above chart we have measured Hygeia Healthcare Holdings' prior ROCE against its prior performance, but the future is arguably more important. If you'd like to see what analysts are forecasting going forward, you should check out our free report for Hygeia Healthcare Holdings.
So How Is Hygeia Healthcare Holdings' ROCE Trending?
Investors would be pleased with what's happening at Hygeia Healthcare Holdings. Over the last five years, returns on capital employed have risen substantially to 10%. The amount of capital employed has increased too, by 408%. The increasing returns on a growing amount of capital is common amongst multi-baggers and that's why we're impressed.
Our Take On Hygeia Healthcare Holdings' ROCE
To sum it up, Hygeia Healthcare Holdings has proven it can reinvest in the business and generate higher returns on that capital employed, which is terrific. And given the stock has remained rather flat over the last three years, there might be an opportunity here if other metrics are strong. With that in mind, we believe the promising trends warrant this stock for further investigation.
One more thing to note, we've identified 1 warning sign with Hygeia Healthcare Holdings and understanding it should be part of your investment process.
While Hygeia Healthcare Holdings isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.
Valuation is complex, but we're here to simplify it.
Discover if Hygeia Healthcare Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:6078
Hygeia Healthcare Holdings
Offers oncology healthcare services in the People's Republic of China.
Adequate balance sheet with moderate growth potential.
Market Insights
Weekly Picks

The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake
NVIDIA will see a profit margin surge of 55% in the next 5 years
Bambuser is today the only listed company in Europe that simultaneously possesses an 85% gross margin, proprietary AI infrastructure for the

Constellium jet another cyclical aluminum processor, or a mispriced aluminum platform?
Recently Updated Narratives
Visa 04-2026

DSV profits will jump by 7.4% thanks to growth trends

$BLCO & $COO The Silence BEFORE the AGM: A Retail Investor’s Timeline, Findings, and Opinion on SUSPICIOUS SILENCE!
Popular Narratives

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.
NVIDIA will see a profit margin surge of 55% in the next 5 years

